3 studies found for:    HYPOCHONDROPLASIA
Show Display Options
Rank Status Study
1 Active, not recruiting Efficacy and Safety Evaluation of Recombinant Human Growth Hormone (r-hGH), Saizen®, on a Population of Children With Hypochondroplasia, Treated at Least 3 Years or Until Near Final Height, When Applicable, in Comparison With a Historic Cohort of Non-treated Children
Condition: Hypochondroplasia
Intervention: Drug: Recombinant human growth hormone (Somatropin)
2 Active, not recruiting C-Type Natriuretic Peptide and Achondroplasia
Conditions: Achondroplasia;   Hypochondroplasia
Intervention:
3 Enrolling by invitation A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin
Conditions: Genetic Disorder;   Achondroplasia
Intervention: Drug: somatropin

Indicates status has not been verified in more than two years